MAP-5 (50 mg) (Canada)
This page contains information on MAP-5 (50 mg) for veterinary use.The information provided typically includes the following:
- MAP-5 (50 mg) Indications
- Warnings and cautions for MAP-5 (50 mg)
- Direction and dosage information for MAP-5 (50 mg)
Map-5 (50 Mg)
This treatment applies to the following species:Active Ingredient(s)
Each vial of MAP-5 (50 MG) contains:|
Sodium hyaluronate acid |
50.0 mg |
|
Sodium chloride USP |
85.0 mg |
|
Sodium phosphate monobasic dihydrate USP |
0.5 mg |
|
Sodium phosphate bibasic dodecahydrate USP |
6.0 mg |
|
Water for injection U.S.P. |
q.s. 10 mL |
The product does not contain preservatives.
MAP-5 (50 mg) Indications
Sterile MAP-5 acts as a replacement for serum and serum products in cell handling and freezing solutions, and thereby reduces the risk of transmitting micro-organisms that may contaminate serum products.MAP-5 is a patented salt of hyaluronic acid in normal saline for use in the collection, handling, culture and cryopreservation of embryos, ova, sperm and other cells.
Precaution(s)
Store at room temperature (10-30°C).Presentation
10 mL vials (5 mg/mL).Nac No.
12150373BIONICHE FOOD SAFETY
231 DUNDAS ST. E., P.O. BOX 1570, BELLEVILLE, ON, K8N 1E2
| Telephone: | 613-966-8058 | |
| Order Desk: | 800-265-5464 | |
| Fax: | 613-966-4177 | |
| Fax Orders: | 613-966-9485 | |
| Website: | www.bioniche.com | |
| Email: | info@bioniche.com |
![]() |
Every effort has been made to ensure the accuracy of the MAP-5 (50 mg) information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert. |
| Printable Version | Email Page |

